Skip to main content
Clinical Trials/NCT05150301
NCT05150301
Unknown
Not Applicable

Study of the Short-term Mortality and Morbidity of Newborns Born at a Gestational Age <32 Weeks of Amenorrhea Outside a Level III Maternity Hospital in Alsace

University Hospital, Strasbourg, France1 site in 1 country134 target enrollmentNovember 1, 2021
ConditionsPremature Birth

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Premature Birth
Sponsor
University Hospital, Strasbourg, France
Enrollment
134
Locations
1
Primary Endpoint
Study of the short-term mortality and morbidity of newborns born at a gestational age <32 weeks of amenorrhea
Last Updated
4 years ago

Overview

Brief Summary

An "outborn" birth is a premature birth that occurs in an unsuitable level center at the end of the child (unlike "inborn" births).

This study aims to describe the morbidity and mortality of very premature newborns (gestational age less than 32 weeks of amenorrhea) born outside a maternity hospital of appropriate level between January 1, 2016 and December 31, 2020, and assessment of the preventable or non-preventable nature of these so-called "outborn" births.

The aim of this research is to write down the short-term mortality and morbidity of newborns born at a gestational age <32 weeks of amenorrhea outside a level III maternity hospital in Alsace between January 1, 2016 and December 31, 2020.

Registry
clinicaltrials.gov
Start Date
November 1, 2021
End Date
October 30, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
University Hospital, Strasbourg, France
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Study of the short-term mortality and morbidity of newborns born at a gestational age <32 weeks of amenorrhea

Time Frame: Files analysed retrospectively from January 01, 2016 to December 31, 2010 will be examined]

Study Sites (1)

Loading locations...

Similar Trials